Progressive Corporation
PGR
$0.00
-2.16%
The Progressive Corporation is a major US property and casualty insurer, primarily focused on underwriting private and commercial auto insurance, alongside specialty lines and homeowners insurance. It is a market leader in personal auto insurance, distinguished by its pioneering use of direct-to-consumer channels and telematics-based pricing models. The current investor narrative centers on the company's ability to navigate a challenging auto insurance market characterized by elevated claims severity, with recent attention focused on its underwriting profitability trends and the potential for margin recovery as rate increases take effect.…
PGR
Progressive Corporation
$0.00
Related headlines
Investment Opinion: Should I buy PGR Today?
Rating & Thesis: Hold. Progressive is a fundamentally strong company trapped in a bearish market narrative, with its attractive valuation offset by a complete lack of positive price momentum and catalyst visibility. The neutral analyst stance (implied target ~$199) supports this view, suggesting the stock is fairly valued at current levels amidst the uncertainty.
Supporting Evidence: The Hold rating is supported by four key data points: 1) The trailing P/E of 11.8x is at the low end of the stock's historical range, suggesting limited valuation downside. 2) Revenue growth remains robust at 12.2% YoY. 3) Profitability metrics are elite, with a 37.3% ROE and $17.2B in TTM FCF. 4) However, the technical picture is abysmal, with the stock down 24.25% over one year and failing to participate in the market rally, as shown by its -9.66 relative strength over one month.
Risks & Conditions: The two biggest risks are a break below $192 support triggering further technical selling, and a reversal of the sequential earnings improvement seen in Q4. This Hold would upgrade to a Buy if the stock establishes a base above $210 with improving momentum, or if Q1 2026 earnings demonstrate sustained margin expansion above 13%. It would downgrade to a Sell on a confirmed break below $192 with high volume, or if revenue growth decelerates below 8%. The stock is fairly valued relative to near-term earnings expectations but undervalued on a long-term, cash-flow basis.
Sign up to view all
PGR 12-Month Price Forecast
The analysis yields a neutral stance, grounded in the conflict between compelling value and powerful negative momentum. The stock is cheap on earnings and a cash flow powerhouse, but the market is clearly discounting these strengths due to sector headwinds. Confidence is medium because the outcome hinges heavily on the next 1-2 quarterly earnings reports, which will test the margin recovery thesis. The stance would upgrade to bullish on a confirmed technical reversal above $225 with strong volume, or downgrade to bearish on a weekly close below $190, which would signal a failure of value support.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Progressive Corporation's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
4 analysts
Implied Upside
—
vs. current price
Analyst Count
4
covering this stock
Price Range
$0 - $0
Analyst target range
Analyst coverage for Progressive is limited, with only 4 analysts providing estimates, which is unusually low for a company of its size and suggests it may be under-followed by the sell-side. The consensus sentiment, inferred from recent institutional actions, is neutral to cautiously optimistic, with firms like B of A Securities maintaining a 'Buy' while others like Morgan Stanley, Jefferies, and UBS have 'Underweight', 'Hold', and 'Neutral' ratings, respectively. The average EPS estimate for the coming period is $15.96, with a range from $14.38 to $17.03. Without a published consensus price target, implied upside must be derived from valuation multiples; using the forward PE of 12.45x and the average EPS estimate suggests a potential price around $199, which is essentially flat to the current price, indicating analysts see the stock as fairly valued at current levels. The target range for EPS is relatively tight, with a high of $17.03 and a low of $14.38, representing a spread of about 18% from the average. This moderate spread signals a reasonable degree of consensus on near-term earnings prospects, with the high target likely incorporating successful margin expansion and the low target factoring in persistent claims inflation. The pattern of recent ratings shows stability, with no upgrades or downgrades in the provided data, reinforcing the prevailing neutral stance.
Bulls vs Bears: PGR Investment Factors
The evidence presents a stark dichotomy: fundamentally strong versus technically broken. The bull case is anchored in superb financials—massive cash flow, high ROE, and attractive valuation—while the bear case is driven by relentless price depreciation and a lack of positive momentum. Currently, the bearish technicals and market sentiment hold stronger sway, as the stock's price action reflects deep skepticism about the auto insurance cycle. The single most important tension is whether Progressive's fundamental strengths (cash flow, profitability) can overcome the severe technical and sentiment headwinds before the latter triggers a break below key support at $192.
Bullish
- Exceptional Free Cash Flow: Progressive generated $17.2 billion in TTM free cash flow, providing immense financial flexibility. This robust cash generation funds a 2.15% dividend yield, share buybacks, and growth investments without reliance on debt, as evidenced by a low D/E ratio of 0.23.
- Strong Profitability & ROE: The company maintains high profitability with a net margin of 12.98% in Q4 2025 and a stellar Return on Equity of 37.3%. This demonstrates superior capital efficiency compared to most financial sector peers.
- Attractive Valuation Metrics: The stock trades at a trailing P/E of 11.8x, near the bottom of its historical range (e.g., 16.15x in Q1 2025). Its PEG ratio of 0.35 suggests it is undervalued relative to its historical growth, presenting a potential value opportunity.
- Solid Revenue Growth Trajectory: Q4 2025 revenue grew 12.2% year-over-year to $22.74 billion, driven by its core Personal Lines segment ($18.71B). This consistent double-digit top-line expansion indicates strong market share gains despite a tough auto insurance market.
Bearish
- Severe Technical Downtrend: The stock is down 24.25% over the past year and trades just 4.6% above its 52-week low of $192.02. It has shown persistent weakness, underperforming the S&P 500 by 54.8% over one year, indicating deep-seated market pessimism.
- Limited Analyst Conviction: With only 4 analysts covering the stock, consensus is neutral to cautious (ratings include Underweight, Hold, and Neutral). The implied price from forward P/E and average EPS is ~$199, offering no upside from the current price of $200.89.
- Volatile Quarterly Margins: Profitability has shown significant quarterly swings, with gross margin ranging from 15.76% in Q3 2025 to 31.28% in Q2 2025. This volatility reflects the ongoing challenge of managing claims costs in an inflationary environment for auto parts and labor.
- High Exposure to Challenging Auto Market: As a market leader in personal auto insurance, Progressive is heavily exposed to persistent headwinds like elevated claims severity. The stock's decline reflects investor concern that rate increases may not fully offset these cost pressures.
PGR Technical Analysis
The stock is in a sustained downtrend, with a 1-year price change of -24.25%, significantly underperforming the S&P 500's +30.59% gain. Trading at a current price of $200.89, it sits just 4.6% above its 52-week low of $192.02, positioning it in the lower 5th percentile of its annual range, which suggests the market is pricing in substantial fundamental headwinds or pessimism. This proximity to the low indicates potential for a value-based bounce if sentiment improves, but also reflects a lack of positive momentum and high risk of further downside if support fails. Recent short-term momentum shows continued weakness, with the stock down 0.96% over the past month and 2.49% over the past three months, diverging sharply from the broader market's strong gains of 8.7% and 3.59%, respectively, over the same periods. This persistent underperformance, evidenced by a 1-month relative strength of -9.66 against the SPY, signals that selling pressure has been consistent and the stock has failed to participate in the recent market rally. Key technical levels are clearly defined, with immediate support at the 52-week low of $192.02 and resistance far above at the 52-week high of $289.96. A decisive break below $192 would likely trigger accelerated selling, while a recovery above the recent trading range near $210 is needed to suggest a stabilization. The stock's beta of 0.33 indicates it has been significantly less volatile than the market during this downtrend, which is atypical for a stock under such pressure and may suggest controlled, institutional selling rather than panic.
Beta
0.33
0.33x market volatility
Max Drawdown
-33.0%
Largest decline past year
52-Week Range
$192-$290
Price range past year
Annual Return
-24.2%
Cumulative gain past year
| Period | PGR Return | S&P 500 |
|---|---|---|
| 1m | -1.0% | +12.6% |
| 3m | -2.5% | +3.1% |
| 6m | -8.3% | +3.9% |
| 1y | -24.2% | +29.7% |
| ytd | -5.3% | +4.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PGR Fundamental Analysis
Revenue growth remains robust, with Q4 2025 revenue of $22.74 billion representing a 12.2% year-over-year increase, continuing a multi-quarter trend of solid top-line expansion driven by premium growth. The Personal Lines Segment, contributing $18.71 billion, is the primary growth engine, while the Commercial Lines Segment added $2.68 billion. This consistent double-digit revenue growth underscores Progressive's ability to gain market share, but the investment case hinges on translating this growth into profit. Profitability is strong but showed some quarterly volatility; Q4 2025 net income was $2.95 billion with a net margin of 12.98%, a significant improvement from the Q3 2025 net margin of 11.62%. The gross margin for Q4 was 29.28%, slightly above the trailing-twelve-month gross margin of 29.47%, indicating stable underlying underwriting economics. The sequential improvement in net income from $2.62 billion in Q3 to $2.95 billion in Q4 suggests positive momentum in managing claims costs. The balance sheet and cash flow position are exceptionally strong, supporting financial flexibility. The company boasts a very low debt-to-equity ratio of 0.23 and a high return on equity of 37.3%. Most notably, free cash flow over the trailing twelve months was a substantial $17.2 billion, providing ample internal capital to fund growth, pay dividends (with a 2.15% yield), and repurchase shares without relying on external financing. The current ratio of 0.59 is low for an insurer but is typical as premiums are collected upfront and liabilities are long-tailed.
Quarterly Revenue
$22.7B
2025-12
Revenue YoY Growth
+0.12%
YoY Comparison
Gross Margin
+0.29%
Latest Quarter
Free Cash Flow
$17.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PGR Overvalued?
Given a positive net income of $2.95 billion, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 11.81x, while the forward PE is slightly higher at 12.45x; this narrow gap suggests the market expects roughly stable earnings in the near term rather than significant growth. Compared to sector averages, Progressive's valuation presents a mixed picture. Its trailing PE of 11.8x is below the typical range for high-quality financials, while its Price-to-Sales ratio of 1.52x and Price-to-Book ratio of 4.40x are more standard for a mature insurer. The PEG ratio of 0.35, based on trailing earnings, indicates the stock is cheap relative to its historical growth rate, but this may reflect market skepticism about future profit growth sustainability. Historically, the stock's current trailing PE of 11.8x is at the low end of its own historical range observed in recent years, where it has frequently traded above 15x. For instance, in Q1 2025, its historical PE ratio was 16.15x. Trading near the bottom of its historical valuation band suggests the market is pricing in a deterioration of its premium growth or profitability prospects, creating a potential value opportunity if the company can demonstrate a sustained earnings recovery.
PE
11.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -31x~137x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Progressive's primary risk is its exposure to volatile underwriting margins in the auto insurance market. While Q4 2025 net margin improved to 12.98%, quarterly gross margins have swung dramatically, from 15.8% to 31.3% over the past year, indicating sensitivity to claims inflation. The company's low current ratio of 0.59 is typical for insurers but underscores the liquidity mismatch between upfront premium collection and long-tailed claim liabilities. Furthermore, its valuation relies on sustaining a high ROE of 37.3%; any material degradation in underwriting profitability would pressure this key metric and the premium P/B ratio of 4.4x.
Market & Competitive Risks: The stock faces significant valuation compression risk, trading near multi-year lows despite solid fundamentals. Its beta of 0.33 indicates it has been less volatile than the market during its downtrend, which may suggest the selling is fundamental and persistent rather than speculative. Competitive and regulatory risks are elevated in the current auto insurance environment, as aggressive pricing to retain market share could undermine the margin recovery narrative. The stock's severe underperformance (-54.8% relative strength vs. SPY) also signals a high risk of continued sector de-rating if macro conditions or interest rates remain unfavorable for financials.
Worst-Case Scenario: The worst-case scenario involves a failure to arrest the downtrend, leading to a break below the critical 52-week low support of $192.02. This could be triggered by a Q1 2026 earnings miss, a guidance cut due to worsening claims severity, or a broader market sell-off that finally catches the low-beta stock. In this adverse scenario, the stock could re-test levels not seen since 2023, with a realistic downside of -15% to -20% from the current price, translating to a range of $160-$170. This aligns with the stock's maximum drawdown of -33.03% over the past year, indicating the potential for significant capital loss if sentiment fails to improve.
FAQ
The key risks are: 1) Operational: Volatility in underwriting margins due to persistent auto claims inflation, as seen in quarterly gross margin swings from 15.8% to 31.3%. 2) Technical: The stock is in a severe downtrend, down 24.25% over one year and trading just 4.6% above its 52-week low; a break below $192 could trigger accelerated selling. 3) Sentiment: Limited analyst coverage with a neutral consensus offers no catalyst for a re-rating. 4) Sector: High exposure to the challenging personal auto insurance market, which remains out of favor with investors.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $195 and $225, as it grinds along meeting earnings estimates without a major catalyst. The Bull Case (30% probability) targets $250-$275, driven by successful margin expansion and a P/E re-rating. The Bear Case (20% probability) warns of a drop to $170-$192 if margins disappoint and support breaks. The base case is most likely, predicated on the assumption that the company executes steadily but investor sentiment remains cautious, keeping the stock range-bound.
PGR is undervalued relative to its own history and growth profile, but fairly valued relative to near-term market expectations. Its trailing P/E of 11.8x is at the low end of its historical range (e.g., 16.15x in Q1 2025), and its PEG ratio of 0.35 is very low. However, the forward P/E of 12.45x implies the market expects roughly stable earnings, and analyst-derived targets suggest fair value around $199. The market is paying a fair price for near-term uncertainty but a discount for long-term cash generation.
PGR presents a complex risk/reward profile. For value-oriented, patient investors, it offers a good buy opportunity due to its low P/E of 11.8x, massive $17.2B free cash flow, and high ROE of 37.3%. However, the 24.25% annual decline and proximity to its 52-week low signal high near-term risk and poor momentum. It is a good buy for those who believe the auto insurance cycle will turn and can wait 12-18 months for a recovery, but a poor choice for short-term traders or those sensitive to volatility.
PGR is unequivocally suitable for long-term investment, not short-term trading. Its low beta of 0.33 and lack of positive momentum make it a poor candidate for short-term gains. However, its strong fundamentals, dividend (2.15% yield), and cash flow support a compelling long-term story for patient capital. A minimum holding period of 2-3 years is suggested to potentially realize the value gap and benefit from the cyclical recovery in auto insurance profitability.
